Semax + Selank Blend

Semax + Selank Blend is a laboratory research formulation combining two synthetic peptides: Semax, a heptapeptide analog of the ACTH(4-10) fragment, and Selank, a synthetic analog of the immunomodulatory peptide tuftsin. The blend is employed in controlled experimental systems to examine concurrent neurotrophic and anxiolytic signaling. Investigators use it to probe interactions between cognitive-pathway markers and stress- or immune-related responses in vitro and in model systems. Material is supplied strictly for laboratory research use only.

Semax is studied for modulation of neurotrophic factor expression, including brain-derived neurotrophic factor (BDNF) pathways, and related gene-expression changes in neuronal cultures and tissue models. Selank is examined for effects on GABAergic and enkephalin-related signaling as well as cytokine regulation in neural and immune cell systems. Co-application of the peptides permits investigation of potential cross-talk between neurotrophic cascades and anxiolytic or immunomodulatory pathways under experimental conditions. All mechanistic observations remain confined to non-clinical research contexts.

Research centers on concurrent neurotrophic signaling linked to Semax and anxiolytic or immunomodulatory signaling linked to Selank. Laboratory work evaluates combined influences on cognition-related markers, stress-response pathways, and neurotransmitter systems such as monoamines and GABA in cell-based and model-organism assays. Additional focus areas include gene-expression profiles involving BDNF and inflammatory mediators when both peptides are present. The blend supports multi-pathway analyses of neural plasticity and adaptive cellular responses in controlled designs.

Individual studies of Semax have reported upregulation of BDNF and related neurotrophic markers in rodent brain tissue and altered performance in certain laboratory learning paradigms. Selank investigations have described modulation of anxiety-like behavioral endpoints in animal models together with shifts in cytokine profiles. These separate findings provide a basis for examining whether co-exposure produces additive or interactive effects on the same endpoints. Direct blend-specific data remain limited and are restricted to preclinical model systems.

Semax + Selank Blend is intended solely for qualified laboratory research and must be handled under institutional biosafety and chemical-safety protocols. Lyophilized material is typically reconstituted in sterile, assay-compatible solvents and stored at recommended temperatures to preserve peptide integrity. Researchers should confirm identity and purity by analytical methods before experimental use. The product is not for human or animal consumption and carries no approved therapeutic or clinical indications.